CCRN

ANALYST NOTE: CCRN (Cross Country Healthcare, Inc.) Date: 2026-06-13 Current Price: $13.17

1. Structural Readiness

• State: Forming
• Aggressive/Pre-Breakout Entry: N/A (Current price is holding within the forming structure)
• Current Price: $13.17
• Extension: N/A (Price has not yet broken out to generate an extension measurement)
• ATR Context: Current ATR is 0.8% (Sub-threshold). This indicates low volatility and a lack of immediate structural momentum. The "ATR at breakout" is not yet recorded as the breakout has not occurred.

2. Thesis Layer

• Thesis Classification: Tactical / Setup-Led
• Secular Exposure: None named at this date.
• Analysis: There is no active macro or secular thesis driving this name as of June 13, 2026. The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals provided in the evidence. No external narrative or "story" is attached to this ticker in the current context.

3. Business Overview

Cross Country Healthcare, Inc. operates as a healthcare workforce solutions provider, delivering talent management services, contingent staffing, and advisory services. The company serves a diverse client base including acute and non-acute care hospitals, outpatient clinics, physician practices, schools, and government facilities.

Key Business Segments & Performance (as of Q1 2026):

• Nurse and Allied Staffing: Represents approximately 84% of total revenue. This segment experienced volume declines in Q1 2026, contributing to a 17.8% year-over-year decrease in service revenue to $241.1 million (Source E10, E11).
• Physician Staffing: Represents approximately 16% of total revenue.
• Growth Drivers:
• Home-Based Staffing: Reported strong organic growth with Q4 2026 revenue of $34 million, up 34% year-over-year (Source E5).
• Education Staffing: Reported Q4 2026 revenue of $18 million, up 48% sequentially as schools returned from recess (Source E6).
• Managed Service Programs (MSP): The company successfully renewed, expanded, and won over $400 million in contract value, predominantly with MSP clients (Source E2).
• Community Care: Cross Country Community Care grew 15.8% year-over-year (Source E13).

Management Expectations (Recorded as of March 4, 2026): Management stated a goal to exit 2026 with a revenue run rate north of $1 billion and an adjusted EBITDA margin of 4% to 5%, with a path to higher margins in 2027 (Source E1, E4). They anticipate travel staffing to be flat to slightly up sequentially, with projected travelers on assignment growing each month into Q2 (Source E3). Management believes the industry has stabilized and is poised for growth in 2026, with clients shifting focus to speed-to-fill rather than rate reduction (Source E7).

4. Archetype and Conviction

• Archetype Candidate: Structurally Broken
• Rationale: The company is attempting to recover from a significant structural disruption. The evidence highlights a prior termination of a merger agreement with Aya (Source E18) and a recent 17.8% revenue decline in the core Nurse and Allied segment in Q1 2026 (Source E10). The "Structurally Broken" archetype fits because the company is in a transition phase, having lost a major strategic partner (Aya) and facing volume headwinds in its primary segment, yet is actively pivoting toward MSP growth and home-based staffing to rebuild.
• Valuation Context: The financial spine indicates a forward consensus EPS of $0.0925 for FY1 and $0.245 for FY2 (Source E25). This suggests the market is pricing in a recovery, but the low absolute EPS figures reflect the current low-margin environment (4-5% EBITDA target).
• Conviction Stack:
• Thesis Strength: Low (No named secular thesis).
• Evidence Quality: Moderate. Strong evidence of operational pivots (MSP wins, home-based growth) but conflicting evidence regarding core volume declines.
• Structural Quality: The "Structurally Broken" nature implies high risk but potential for rerating if the turnaround executes.
• Setup Readiness: The forming coil suggests the market is digesting the news, but the sub-threshold ATR (0.8%) indicates a lack of conviction from the broader market.
• Rerating Potential: Dependent on the successful execution of the $1B revenue run rate and the stabilization of the Nurse and Allied segment.

5. Invalidations, Strengths, and Gaps

• Gaps in Evidence:
• Merger Status: While the Aya merger was terminated (Source E18), the evidence mentions a new merger agreement with "KL Criss Cross Intermediate, LLC" entered on May 6, 2026 (Source E14). The status of this new merger (e.g., regulatory approval, closing timeline) is not detailed in the provided evidence, creating a gap in understanding the ultimate corporate trajectory.
• Margin Trajectory: While management targets 4-5% EBITDA, the actual Q1 2026 margin is not explicitly stated, only the target.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Management guidance for $1B revenue run rate and 4-5% EBITDA margin by year-end; successful $400M MSP contract renewal and expansion; strong sequential growth in Education Staffing (+48%) and Home-Based Staffing (+34%). Key risks: Core Nurse and Allied revenue declined 17.8% in Q1 2026; sub-threshold ATR (0.8%) indicates weak market momentum; pending status of new KL Criss Cross merger; low forward EPS consensus ($0.09 FY1) reflects fragile fundamentals. Sizing hint: Position size should be minimal due to the "Structurally Broken" archetype and lack of confirmed breakout; treat as a high-risk tactical observation rather than a core holding. Expected path: If the thesis holds, the company will stabilize the Nurse and Allied segment while MSP and home-based growth offset declines, leading to a technical breakout above the forming coil resistance as earnings confirm the margin targets. Expected horizon: 3 to 6 months to confirm the turnaround and technical breakout.